Categories
Health

Boston Physician Develops Extreme Allergic Response After Getting Moderna Vaccine

Moderna’s vaccine, like Pfizer’s, is based on a molecule called messenger RNA, or mRNA, that is injected into the upper arm. Once inside human cells, the mRNA directs the production of a protein called spike, which teaches the immune system to recognize and thwart the coronavirus should it ever enter the body. Each vaccine contains a handful of other ingredients that wrap the fragile mRNA in a protective fat bubble and help keep the prescription stable during transit.

None of the ingredients in any of the vaccines have been identified as common allergens. However, several experts have cautiously pointed to polyethylene glycol or PEG, which appears as a possible culprit in both recipes, albeit in slightly different formulations. PEG is found in a wide variety of pharmaceutical products, including ultrasound gel, laxatives, and injectable steroids, and allergies to it are extremely rare.

Dr. Kuruvilla said it was still possible that something else was responsible and more research was needed to determine the cause of these events.

Dr. Kimberly Blumenthal, an allergist and immunologist at Massachusetts General Hospital, noted that anaphylaxis is sometimes difficult to confirm without blood tests looking for an enzyme called tryptase, which is released in allergic reactions. It is important that logs are in place so that similar cases can be investigated further.

Based on data obtained from late-stage clinical trials, Moderna has not reported any associations between vaccine and anaphylaxis. When products from closely monitored studies become widely available, rare side effects may occur.

The recent allergic reactions related to Pfizer’s very similar vaccine sparked heated discussion during the FDA and CDC panel discussions earlier this month. Experts noted that anaphylaxis was becoming unusually common this soon. (Under normal circumstances, allergic reactions to vaccines are believed to occur at the rate of about one in a million.)

Denise Grady and Noah Weiland contributed to the coverage.

Categories
Health

New York Gov. Andrew Cuomo updates the general public as state rolls out Covid vaccines

[The stream is slated to start at 11:30 a.m. ET. Please refresh the page if you do not see a player above at that time.]

New York Governor Andrew Cuomo will hold a press conference Wednesday on plans to distribute Covid-19 vaccines amid threats of further economic shutdown of the state.

Last week, Cuomo and New York City Mayor Bill de Blasio noted that the state may close non-essential stores in some regions in January. For weeks, Cuomo has been saying he will put more restrictions in parts of the state where hospitals are so overwhelmed they can’t care for every patient.

However, he has determined that it is up to New York residents to follow public health precautions to limit the spread of the coronavirus and avoid a shutdown.

“Of course, a shutdown in January is possible,” Cuomo said last week. “But there is a big but,” he said and spelled the word “BUT” one letter at a time.

– CNBC’s Noah Higgins-Dunn contributed to this report.

Read CNBC’s live updates for the latest news on the Covid-19 outbreak.

Categories
Health

Turkey and Brazil Say Chinese language Vaccine Efficient, With Sparse Supporting Knowledge

Turkish officials announced Thursday that a vaccine made by Chinese company Sinovac has an efficacy rate of 91.25 percent. However, the finding is based on preliminary results from a small clinical study, and none of the data has been published in a journal or published online.

The announcement came a day after another ambiguous press conference, also on Sinovac’s vaccine, in Brazil. Officials there were expected to provide detailed results from another study, but they only reported that the vaccine had an efficacy rate of over 50 percent.

A total of 7,371 volunteers were involved in the Turkish study, but efficacy data from Infectious Disease Expert Serhat Unal was based on just 1,322 participants, of whom 752 received a real vaccine and 570 received the placebo.

Dr. Unal said that 26 of the volunteers who received the placebo developed Covid-19 while only three of the vaccinated volunteers became ill. He and his colleagues did not pass on their data in writing.

“Now we are sure that the vaccine is effective and safe for the Turks,” said Fahrettin Koca, the health minister.

Sinovac did not make a public statement about the trial, nor did he comment on the trial in Brazil.

Updated

Apr. 25, 2020, 4:08 pm ET

The small number of volunteers that the Turkish researchers relied on to calculate effectiveness raised questions about the safety of their conclusions. The more people take part in a vaccine clinical study, the more statistical it is.

In contrast, Pfizer and BioNTech provided data on 36,523 people to show that the vaccine had a 95 percent effectiveness rate. For their vaccine, 162 people who received the placebo developed Covid, compared to eight people in the group who received the vaccine.

Turkey has signed a contract with Sinovac for 50 million doses of the vaccine. The first three million cans are due to arrive in Turkey on Monday, Koca said. Mr Koca said Turkey will also receive 4.5 million doses of the Pfizer BioNTech vaccine by the end of March. Around 1 million cans are expected to arrive by the end of January, he said.

CoronaVac, as Sinovac calls its vaccine, is made from killed coronaviruses. The method is one of the oldest for making vaccines that Jonas Salk used to make a vaccine against polio in the 1950s. After viruses are inactivated with chemicals, they cannot make people sick, but they can stimulate the immune system to make antibodies that can provide long-term protection against live viruses.

Sinovac developed CoronaVac in early 2020 and then conducted a number of clinical studies. They published their results in November. There they reported that the vaccine appeared safe and produced an immune response against the coronavirus.

The company then moved on to phase 3 trials in Brazil, Indonesia and Turkey, three countries with high rates of Covid-19.

Health officials in Brazil said Wednesday that the Chinese vaccine had passed safety and effectiveness tests that would pave the way for its use in Brazil. However, they postponed the publication of detailed data from clinical trials in Brazil on which these results are based, citing a contractual agreement with Sinovac. Dimas Covas, the director of the butantane institute that conducted the trials, said a joint announcement could be made within two weeks.

“Today is a historic day for science and for Brazilian health,” Jean Gorinchteyn, Sao Paulo State Minister of Health, told reporters at a press conference. “This will allow us to save the lives of millions of people, not just in Brazil, but around the world.”

Categories
Health

Trump threatens to derail US stimulus

LONDON – European markets closed higher on Wednesday as investors hoped a Brexit trade deal could be reached amid concerns over approval of a long-belated US coronavirus stimulus package.

The Europe-wide Stoxx 600 Index tentatively closed 1.1% with Travel & Leisure stocks rising 3.67% to lead earnings. Healthcare stocks bucked the trend, slipping 0.4%.

On Tuesday, EU chief negotiator for Brexit, Michel Barnier, said the bloc was making a “final push” to reach a Brexit trade deal with the UK, but disagreements persist over fishing rights. There were positive reports of the talks, with ITV’s Robert Peston claiming an agreement could be reached on Wednesday.

In the United States, President Donald Trump proposed on Tuesday not to sign the US $ 900 billion Covid Aid bill passed by Congress earlier this week. Trump called the move an inappropriate “disgrace” and urged lawmakers to make a number of changes, including larger direct payments to individuals and families.

On Wall Street, major US indices were moderately higher in the opening moments of trading on Wednesday. The Dow was up 130 points and the S&P 500 was up 0.3%. The Nasdaq Composite lagged 0.2%.

Back in Europe, France reopened its border with England on Wednesday. Passengers arriving at the border must have a negative coronavirus test result. It did so after France imposed a ban on people and cargo from the UK amid concerns about the apparently fast-spreading strain of Covid first identified in the south-east of England.

Concerns about the economic impact of the UK’s tough new lockdown measures to contain the spread of the new strain of coronavirus, as well as ongoing uncertainty over Brexit, have weighed on investor sentiment recently.

Travel and leisure stocks got a boost from news that France lifted its travel restrictions on Wednesday. The industry leaders included the German airline Lufthansa with an increase of 4.3% and the aircraft manufacturer Airbus with an increase of 4.6%.

In terms of individual stocks, financial institution Lloyds climbed 7% to the top of the Stoxx 600.

In the European benchmark, the German manufacturer of medical packaging Gerresheimer fell by 2.8%, while the supplier of meal sets HelloFresh fell by more than 5%.

Categories
Health

Covid Vaccine Launch Evokes Reminiscences of Polio Period

The initial introduction of the polio vaccine did not go smoothly. Within one month, six cases of polio were linked to a vaccine manufactured by Cutter Laboratories in Berkeley, California. It soon emerged that Cutter hadn’t completely killed the virus in some batches of vaccine, a mistake that caused more than 200 cases of polio and 11 deaths. The surgeon general asked Cutter to call back and halt distribution.

Months later, in the summer and fall of 1955, a polio outbreak struck Boston and Ellen Goodman, then 6, fell ill. “I remember being in bed and feeling this electrical current move my arms and legs up and down,” she said. “Then I started moving and my left leg was numb.”

Decades later, Ms. Goodman, 71, had post-polio syndrome with symptoms such as chronic fatigue and difficulty walking. “My life has been determined by this disease,” she said. “To think it could have been avoided.”

The vaccination program restarted months later and polio cases fell sharply. Elvis Presley agreed to be vaccinated on national television to increase public confidence in the admission. But the disease has not gone away. The number of US cases rose again from 1958, particularly in urban areas. The last fall in the country due to community expansion was recorded in 1979. Although two types of polio have been eradicated, a third remains in Afghanistan and Pakistan and is still in circulation.

For those marked by memories of the polio epidemic, a vaccine for Covid cannot arrive soon enough. Many older Americans who are particularly susceptible to the disease have been incarcerated and separated from their children and grandchildren for much of this year.

Ms. Norville hasn’t left home since February and is eagerly awaiting a shot. “My son said, ‘If I could, I would bring you the vaccine today.'”

For the Salk family, relief comes with a sense of pride, as the father plays the role of advancing the scientific understanding of immunization. But the sons are also concerned about resistance to vaccination against any disease.

Categories
Health

Biden advisor Dr. Atul Gawande was in Moderna trial

Dr. Atul Gawande, a coronavirus advisor to President-elect Joe Biden, told CNBC on Wednesday that he had participated in Moderna’s Covid-19 vaccine study.

“My mom, 84, said, ‘I want to give something back,’ so she signed up for the trial. I said if my mom can, I’ll sign up for a vaccination trial,” said Gawande at the Squawk Box . “

Massachusetts-based Moderna was eventually the company to offer a study nearby, said Gawande, a surgeon at Brigham and Women’s Hospital in Boston and a professor at Harvard University. He said he received his first shot in August and “felt almost nothing”. However, when he received the second dose in late September, it was a different story.

“Two days later, I had a fever, chills and had to stay home,” said Gawande, who is also chairman of Haven, the joint healthcare company of Amazon, Berkshire Hathaway and JPMorgan Chase. “I haven’t had to take a day out of my practice or public health work in over a year. I barely let anything knock me down, but it knocked me down. Then, about 24 hours later, I was back on my feet and.” I’m fine. “

Gawande’s reflection on his experience comes from Americans being immunized against Covid-19 for the first time outside of clinical trials, starting last week with Pfizer’s vaccine and this week with Modernas. 614,117 doses were administered on Monday morning, according to a tracker from the Centers for Disease Control and Prevention.

Gawande said he didn’t know if he received the vaccine or was in the study placebo group. While he suspects the side effects he was experiencing were due to the actual vaccine, he said it was possible that it was a psychological reaction to taking the placebo. He added that his mother “had little reaction” to gunfire received in her clinical trial.

Vaccine side effects are not necessarily a cause for concern, Gawande said. “That’s the immune system that comes on and your antibodies are made against the virus,” he said.

Gawande is part of a team of doctors and health professionals advising Biden during the coronavirus pandemic transition. On Monday, Biden was vaccinated on live television in hopes of encouraging other Americans to be ready to receive the shot. “There’s nothing to worry about. I’m looking forward to the second shot,” said Biden.

Biden said Tuesday that Americans must remain vigilant about the coronavirus over the holidays, even though the vaccine has begun to spread. “Meanwhile, the pandemic rages on. Experts believe it could get worse before it gets better,” he said.

Gawande gave a similar outlook on Wednesday, saying the current high infection rates in the country will lead to more deaths from Covid-19 in the coming weeks and months.

“We have 300,000 deaths. Already the next 100,000 deaths are branded in, with new infections in the last week or so,” said Gawande. “It’s really about whether we can avoid the 500,000 deaths, which is really just terrible to think about.”

Categories
Health

U.S. to Require Adverse Covid-19 Check for All Vacationers From U.Okay.

The United States will require all passengers arriving from the UK to test negative for the coronavirus within 72 hours of their departure, the Centers for Disease Control and Prevention said Thursday.

The move comes as a new highly transmissible variant of the virus, which first appeared in the UK, has led countries to seal their borders to travelers from there.

The new rule, which goes into effect on Monday, applies to both Americans and foreign nationals and requires passengers to provide evidence of a negative result in a genetic test known as a PCR or antigen test.

“This additional test requirement will strengthen our protection of the American public to improve their health and safety and to ensure responsible international travel,” the CDC said in a statement.

Passengers are required to provide the airline with “written documentation of their laboratory test result (in print or electronic form),” the CDC said, adding, “If a passenger does not take a test, the airline must refuse to board the passenger.”

The new rules were a reversal for the Trump administration, which initially told American airliners that the government would not require testing for travelers from the UK.

United Airlines, Virgin Atlantic and Delta Air Lines had already announced similar guidelines requiring all passengers on their flights between the UK and the United States to provide evidence of a negative test result within 72 hours of departure. British Airways also requested negative test results for passengers arriving in New York.

Several of the airlines announced their policies after New York Governor Andrew M. Cuomo requested that passengers coming from London to John F. Kennedy International Airport must document a negative test result.

“We cannot allow history to repeat itself with this new variant,” Mr Cuomo wrote on Twitter.

Also on Thursday, New Jersey Governor Phil Murphy said that passengers arriving at Newark Airport would require negative tests within 72 hours of departure to enter.

American travel requirements are less draconian than those of other countries in Europe and Asia, which excluded all travelers from the UK after the advent of the new coronavirus variant. Experts are skeptical that travel bans can stop the spread of the variant. Dr. Anthony S. Fauci, the leading U.S. infectious disease expert, said there was a good chance the variant was already in the country.

“I don’t think such a draconian approach is necessary,” he said of a travel ban for PBS NewsHour. “I think we should give serious thought to the possibility of requiring people to be tested before they come here from the UK.”

A recent study by British scientists found no evidence that the variant was more lethal than others. However, the researchers estimated that it was 56 percent more contagious. The country also announced a travel ban from South Africa after Health Secretary Matt Hancock said two people were discovered with another variant that had surfaced in the African country. Another variant has also appeared in Nigeria.

The UK authorities this week put much of England under renewed restrictions on travel and socializing, warning that schools and universities may have to close soon.

Vivian Wang contributed to the coverage.

Categories
Health

The plant-based meat trade is on the rise, however challenges stay

A visitor tries a plant-based meat substitute at the Restaurant & Bar and Gourmet Asia Expo at the Hong Kong Convention and Exhibition Center in Hong Kong on November 11, 2020.

Peter Parks | AFP | Getty Images

SINGAPORE – The demand for meat alternatives has increased and will continue to increase, but the industry still has hurdles to overcome in various parts of the world, analysts said.

According to Google Trends, global search interest for the term “plant-based meat” skyrocketed in early 2019 months before Beyond Meat went public.

The global meat substitute sector is valued at $ 20.7 billion and is expected to grow to $ 23.2 billion by 2024, market research firm Euromonitor told CNBC.

This growth is being fueled by concerns ranging from animal welfare to food security to the Covid-19 pandemic.

“In times of shock and instability, building a low-risk value chain means focusing on opportunities, and the shift towards plant-based meat is showing no signs of slowing,” said Elaine Siu, executive director of The Good Food Institute Asia -Pacific.

However, obstacles remain for the burgeoning market.

Cultural barriers

The plant-based meat market in Asia could be constrained by established perceptual issues, Siu said.

For example, pig meat, or vegetarian meat, used to be mainly eaten by Buddhist practitioners in China, she said.

“The replication of the taste and texture of meat has never been pushed beyond relatively basic levels,” she said, adding that these traditional products serve a specific purpose and “are considered to be of limited appeal to certain groups.”

“In order for plant-based meat to develop its full market potential in Asia, the sector must continue to break away from its association with traditional fake meat, which is expected to be sold at a low price and which carries historical image baggage.” said Siu.

Objections from the traditional meat industry

Ranchers could also stand in the way of the alternative protein sector, particularly in the US, said Simon Powell, global head of thematic research at the American bank Jefferies.

The US Cattlemen’s Association filed a petition in 2018 calling for an official definition of the terms “beef” and “meat” to keep vegetable proteins out of the description.

A herd of cattle gathers in the shade of an old barn in Owings, Maryland on May 4, 2020.

Mark Wilson | Getty Images News | Getty Images

“Incumbent producers will be working hard with their governments to change labeling and play around with consumer advertisements to say it can’t be called meat,” Powell told CNBC of Zoom. “I think that’s possibly one of the biggest obstacles.”

The European Union rejected proposals in October to ban restaurants and shops from using words such as sausage or burger to describe meat alternatives.

Consumer confidence, consumer fatigue

Powell added that if any of the vegetable meat companies had “an accident” or an issue with their recipe that resulted in a “massive recall”, customers could fear consuming these alternatives.

“This is a big ‘if’ … but if they have a big recall of products, it could hurt consumer confidence,” he said. “Eventually you will get these events. It will set the industry back a little.”

Separately, Powell said the “instagrammability” of plant-based foods is one reason the market is growing “all over the world”. The market’s growth could be hampered as the novelty of meat alternatives wears off or wears off, he said.

Categories
Health

How Midwives Have Stepped in in Mexico as Covid-19 Overshadows Childbirth

Rafaela López Juárez was determined that if she ever had another child, she would try to give birth at home with a trusted midwife who is surrounded by family. Her first hospital birth had been a traumatic ordeal, and her perspective changed drastically afterwards when she trained as a professional midwife.

“What women want is a birthing experience that is centered on respect and dignity,” she said. She believes low risk births should take place outside of hospitals, at home, or in dedicated birthing centers where women can choose how to give birth.

In late February, Ms. López and her family awaited the arrival of their second child at their home in Xalapa, Mexico as they followed the threatening news of the coronavirus pandemic invading. She gave birth to Joshua, a healthy boy, on February 28, the day Mexico confirmed its first case of Covid-19. Ms. López wondered how the pandemic would affect her job.

About 96 percent of births in Mexico occur in hospitals, which are often overcrowded and poorly equipped. Many women describe being treated badly or disrespectfully. The pandemic outbreak raised concerns that pregnant women in hospitals could be exposed to the virus, and women’s health advocates in Mexico expressed hope around the world that the crisis could become a catalyst for lasting changes to the system.

A national movement has made determined but uneven progress in integrating midwives into Mexico’s public health system. Some authorities argue that well-trained midwives would be of great value, particularly in rural areas, but also in small non-surgical clinics across the country. However, until now there has not been enough political will to provide the regulation, infrastructure and budgets necessary to employ enough midwives to make a significant difference.

In the first few months of the pandemic, there was isolated evidence that midwives were gaining importance in the country. Midwives across Mexico have been inundated with requests for home births. The government encouraged state agencies to set up alternative health centers that focus exclusively on childbirth and could be staffed with nurses and midwives.

As the outbreaks of Covid spread, health officials across the country saw a sharp drop in prenatal consultations and hospital births. At Acapulco General Hospital in the Mexican state of Guerrero, Dr. Juan Carlos Luna, the director of maternal health, found a 50 percent decrease in births. Since skeleton workers sometimes worked in double shifts, doctors and nurses were enforced under difficult conditions. “Almost everyone on my team has tested positive for the virus at some point,” said Dr. Luna.

In the intensive care unit Covid-19 in Acapulco General, doctors treated María de Jesús Maroquín Hernández. She had developed breathing problems in the 36th week of pregnancy and asked her family to drive her to the hospital for four hours. Doctors isolated Ms. Maroquín while her family waited outside as funeral directors carried away the dead Covid patients, worrying that she would be next. She was released five days later and soon gave birth via a caesarean section in a hospital near her home. She and her husband decided to name their little girl Milagro – miracle.

In Mexico’s indigenous communities, women have long relied on traditional midwives, who are becoming even more important today. In Guerrero, some women have given birth to midwives in special indigenous women’s centers called CAMIs (Casas de la Mujer Indígena o Afromexicana), where women can also seek help with domestic violence, which according to CAMI staff has increased. However, austerity measures in connection with the pandemic have deprived the centers of essential funds from the federal government.

Other women have chosen to quarantine themselves in their communities for help from midwives like Isabel Vicario Natividad, 57, who continues to work despite their own health conditions making them vulnerable to the virus.

As Covid-19 cases in Guerrero increased, state health officials reached out to women and midwives in remote areas with potentially high maternal and child mortality rates.

Updated

Apr. 24, 2020, 8:33 am ET

“If the women are too scared to come to our hospitals, we should look for them where they are,” said Dr. Rodolfo Orozco, director of reproductive health in Guerrero. With the support of a handful of international organizations, his team recently started visiting traditional midwives for workshops and handing out personal protective equipment.

In the capital Chilpancingo, many women discovered the Alameda Midwifery Center, which opened in December 2017. In the early stages of the pandemic, the center’s birth rate doubled. In October, Anayeli Rojas Esteban, 27, traveled to the center for two hours after her local hospital was unable to admit her. She was pleasantly surprised to find a place with midwives who actually allowed her to give birth in the company of her husband, José Luis Morales.

“We’re especially grateful that they weren’t cut like they were when they were first born in the hospital,” said Morales, referring to an episiotomy, a surgical procedure that is routine in hospital settings but is increasingly viewed as unnecessary.

While Mexico’s state health authorities battled to contain the virus, the situation in the country’s capital highlighted the dangers and frustrations women felt.

In the spring, health officials in Iztapalapa, Mexico City’s most densely populated neighborhood, got mixed up as the area became the center of the country’s coronavirus outbreak. The city government converted several large public hospitals in Iztapalapa into treatment facilities for Covid-19 patients, leaving thousands of pregnant women desperate for alternatives. According to Marisol del Campo Martínez, the clinic’s manager, many have sought refuge in maternity clinics such as Cimigen, where the number of births doubled and the number of prenatal visits quadrupled.

Other expectant mothers joined the growing number of women seeking a home delivery experience for safety reasons and to avoid potentially unnecessary cesarean sections. In Mexico, around 50 percent of babies are delivered by caesarean section, and pregnant women are pressured by their peers, family members and doctors to perform the procedure.

In July, 30-year-old Nayeli Balderas, who lived near Iztapalapa, reached out to Guadalupe Hernández Ramírez, an experienced perinatal nurse and president of the Association of Professional Midwives in Mexico. “When I started doing research on humanized childbirth, breastfeeding, etc., a whole new world opened up to me,” said Ms. Balderas. “But when we told our gynecologist about our plan, her whole face changed and she tried to scare us.” Undaunted, Mrs. Balderas proceeded with her birth plan.

Their work was long and increasingly difficult. After 12 hours, Ms. Balderas and her husband discussed with Ms. Hernández and decided to activate their plan B. At 3 a.m., they rushed to Dr. Fernando Jiménez, a gynecologist and colleague of Ms. Hernández, where it was decided that a caesarean section was needed.

Across Mexico City, 26-year-old Maira Itzel Reyes Ferrer had also screened home births in September and found María Del Pilar Grajeda Mejía, a 92-year-old certified traditional midwife who works with her granddaughter Elva Carolina Díaz Ruiz, 37 , trained obstetrician. They guided Ms. Reyes through a successful home birth.

“My family admitted that sometimes they were concerned during childbirth,” Ms. Reyes said. “But in the end they loved the experience so much that my sister is now taking a midwifery course. She has already paid and started! “

At the start of winter, Mexico faces a devastating second wave of the coronavirus. The hospitals in Mexico City are quickly running out of space. The much-discussed birth centers run by state midwives have not yet come into being, and medical staff in renowned hospitals such as the National Institute of Perinatology or INPer work around the clock.

At the beginning of the pandemic, INPer employees found that around a quarter of all women admitted to the hospital tested positive for the coronavirus. The administrators set up a separate Covid-19 ward, and Dr. Isabel Villegas Mota, head of the hospital’s epidemiology and infectious diseases department, managed to ensure adequate personal protective equipment for staff. Not all front-line workers in Mexico were so lucky. The Covid-19 death rate for medical workers in Mexico is among the highest in the world.

When Grecia Denise Espinosa learned that she was pregnant with twins, she planned to give birth in a well-known private clinic. But she was shocked at the high cost and decided to see doctors at INPer instead. To her surprise, when she got to the hospital in November, she tested positive for the virus and was sent to the Covid-19 department, where doctors performed a c-section.

Maternal health advocates have long said that Mexico’s model of obstetrics needs to change to focus on women. If ever there was a moment for health officials to dedicate themselves fully to the midwife, now is the time to argue that the thousands of midwives across the country could help ease the pressure on an overburdened and often suspicious healthcare system and provide quality care to women.

“The model we have in Mexico is an outdated model,” said Dr. David Meléndez, technical director of the Safe Motherhood Committee Mexico, a non-profit organization. “It’s a model where we all lose. The women lose, lose the land, and lose the health system and medical staff. We are stuck in the middle of a global pandemic with a bad model at the worst possible moment. “

picture

Janet Jarman is a Mexico-based photojournalist and documentary filmmaker and director of the documentary “Birth Wars”. It is represented by Redux Pictures.

Categories
Health

Trump’s risk to veto $900 billion Covid reduction invoice places main local weather laws in danger

Patrick Pleul / Image Alliance via Getty Images

President Donald Trump’s opposition to a $ 900 billion coronavirus bailout package, largely passed by U.S. lawmakers late Monday, jeopardizes the first major climate change piece of legislation to have received Congress approval in about a decade.

Trump has threatened a veto of the stimulus package, which includes $ 600 direct checks for individuals and $ 35 billion to fund clean energy projects, and plans to reduce the use of chemicals to warm the planet.

The climate regulations included in the deal come after the Trump administration slashed more than 80 key environmental regulations in four years and just before President-elect Joe Biden took office.

Biden plans to rejoin the Paris Climate Agreement and use executive orders to expose many of Trump’s environmental setbacks. He’s also pushing for a $ 2 trillion plan, which needs Congressional approval, to move the country from fossil fuels to clean energy and green jobs. Trump officially withdrew the country from the Paris Agreement in November.

Although Biden’s legislation is likely to face immense hurdles if the GOP controls the Senate, which will be decided with two crucial runoff elections in Georgia in January, policy experts and environmental groups say the bipartite-backed climate action in the stimulus package signals that Biden can achieve this could make significant strides in combating global warming. It is also a sign that the US will join a wider global effort to reduce fossil fuel emissions to warm the planet.

“The spending bill just passed by Congress, with support from both Democrats and Republicans, points the way ahead,” said Michael Mann, climatologist and professor of atmospheric science at Penn State University. “It’s a positive sign that 2020 could be the year we turned around the corner on climate action in the US.”

The stimulus plan will cut the production and consumption of fluorocarbons (HFCs), which warm the planet, by 85% in the US over a 15 year period.

The ozone-depleting chemicals are often found in air conditioners and refrigerators. While they make up a smaller percentage of greenhouse gas emissions, fluorocarbons pack 1000 times the heat storage capacity of carbon dioxide.

More from CNBC Environment:
Rethinking Stimulus: How Covid’s Economic Recovery Can Combat Climate Change
Biden will rejoin the Paris Climate Agreement. Here’s what happens next

HFCs are used by nations around the world in a targeted manner to curb global warming. In October 2016 in Kigali, Rwanda, a landmark agreement was reached by delegates from 197 nations around the world to phase out HFCs.

So far 72 countries have ratified the Kigali Agreement. Despite the support of US manufacturers and chemical companies, the Trump administration did not accept the pact and instead proposed to reset the Obama-era standards to reduce the use of HFCs.

The stimulus package also includes bipartisan renewable energy legislation, which will provide approximately $ 35 billion in government funding for clean energy projects.

“This bill is the most important step we have taken to improve the climate of this Congress, and its passage is strong evidence that both parties support cooperation in creating climate solutions and investing in advanced energy technologies, while at the same time the our country’s most vulnerable citizens are cared for, “Senator Chris Coons, D-Del. said in a statement earlier this week.

The legislation includes tax credits for solar and wind power that would fuel Biden’s plan to have a carbon-free electricity sector by 2035. The broader bill also includes investments for more sustainable transport and re-approves a program that provides funding for low-income homeowners to upgrade equipment, heat pumps and other household items to clean energy products.

The stimulus package also includes measures to capture and store carbon from production and power plants, reduce diesel emissions from some vehicles, and finance oil exploration projects.

“Congress has made an unprecedented downside to tackling climate change in this legislation by agreeing to phase out effective HFCs, invest in renewables and extend much-needed tax incentives for wind and solar,” said Grant Carlisle, senior Policy Advisor at Natural Resource Defense Council.

“But that’s just a start,” said Carlisle. “In order to cope with the climate crisis, the federal government must accelerate its efforts to convert our economy to clean energy and away from dirty fossil fuels.”